Connect | Scientific Sessions

Screenshot 2021 11 02 130142

Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack

Experts will discuss reducing ischemic and bleeding risk with antiplatelet therapy in patients with CAD, and explain the evidence for DAPT in acute ischemic stroke/TIA and the need for its early use in appropriate individuals

Live Meeting Image

Member Connect

P104 Steven Botts Image

Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells

(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA

The latest science in heart failure

(From left to right): Danielle Belardo, MD, Rafael Diaz, MD, and Christie Mitchell Ballantyne, MD, FAHA

Trials’ results highlight the potential for fish oil to fight COVID-19 and MK-0616 to lower cholesterol

(left to right): Jacqueline E. Tamis-Holland, MD, and Jane Armitage, FRCP, FFPH, OBE

New drugs, indications in cardiovascular disease

Researchers present research regarding aspirin and dementia, early P2Y12 inhibitors, ticagrelor reversal agent and oral factor XIa.

Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD

Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption

Lp(a) and Peripheral Artery Disease Toolkit

Lp(a) and Peripheral Artery Disease Toolkit

This toolkit raises awareness of Lp(a), why it is important to measure in addition to LDL, how Lp(a) intersects with PAD and more.

Marko Banovic, MD, PhD

Valves, veins and new viewpoints in cardiothoracic surgery

Trials’ results shed light on a new device for extending vein graft durability, the timing of bypass surgery after Ticagrelor cessation and aortic valve replacement, and best practices for concomitant tricuspid valve repair.

Getty Images 537596177

LBS coverage (2020): AF trials reveal pragmatic screening and intervention opportunities